63816-12-6 Usage
Chemical family
Belongs to the quinolone family of compounds.
Structure
Characterized by a quinolone ring structure with an ethyl group at the 1 position and a methoxy group at the 6 position.
Applications
Commonly used as a building block in the synthesis of various pharmaceuticals and agrochemicals.
Biological properties
Studied for its potential anti-inflammatory and anti-cancer activities.
Chelating agent
Has shown potential as a chelating agent in metal ion coordination chemistry due to its nitrogen and oxygen donor atoms in the quinolone ring.
Research interest
Continues to be of interest to researchers in various fields, including pharmaceuticals, agrochemicals, and metal ion coordination chemistry.
Diverse range of applications
Has a diverse range of applications in different industries and research areas.
Check Digit Verification of cas no
The CAS Registry Mumber 63816-12-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,8,1 and 6 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 63816-12:
(7*6)+(6*3)+(5*8)+(4*1)+(3*6)+(2*1)+(1*2)=126
126 % 10 = 6
So 63816-12-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H13NO2/c1-3-13-11-6-5-10(15-2)8-9(11)4-7-12(13)14/h4-8H,3H2,1-2H3
63816-12-6Relevant articles and documents
2-[3H-THIAZOL-2-YLIDINEMETHYL]PYRIDINES AND RELATED COMPOUNDS AND THEIR USE
-
Page/Page column 47, (2009/10/06)
The present invention pertains to certain 2-[3H-thiazol-2-ylidinemethyl]pyridine compounds and analogs thereof, which, inter alia, inhibit cell proliferation, treat cancer, etc., and more specifically to compounds of the following formula, wherein RA1, RA2, RA3, RA4, RB1, RB2, RNA, RNB, and X? are as defined herein: The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit cell proliferation, and in the treatment of proliferative conditions such as cancer, etc.